Jane Herald
Family Medicine · Jasper, ALNPI 1144772591
Payments from drug & device makers
Across 472 payments — averaging $15.23 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- GSK$920
- Novo Nordisk$566
- Pfizer$392
- AstraZeneca$381
- Amgen$289
- plus $3K from 36 others
What the payments were for
- Food & beverage$7,188100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
How this compares
$7,188 in reported general payments places this provider in the 85th percentile of 1,680 family medicine providers in Alabama.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 78 | $93,589 |
| EliquisApixaban | 125 | $85,974 |
| FarxigaDapagliflozin Propanediol | 64 | $53,781 |
| JanuviaSitagliptin Phosphate | 58 | $51,074 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 50 | $49,312 |
| XareltoRivaroxaban | 50 | $48,558 |
| JardianceEmpagliflozin | 45 | $36,134 |
| MounjaroTirzepatide | 23 | $29,495 |
| LinzessLinaclotide | 40 | $26,847 |
| EntrestoSacubitril/Valsartan | 22 | $21,411 |
| RexultiBrexpiprazole | 15 | $21,351 |
| MyrbetriqMirabegron | 24 | $16,198 |
| Victoza 3-PakLiraglutide | 11 | $10,294 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 16 | $9,711 |
| JanumetSitagliptin Phos/Metformin Hcl | 14 | $9,197 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $566 | $93,58978 claims |
| PfizerEliquis | $392 | $85,974125 claims |
| MerckJanuvia, Janumet, Belsomra | $65 | $65,19083 claims |
| AstraZenecaFarxiga, Breztri Aerosphere | $381 | $63,49280 claims |
| GSKTrelegy Ellipta, Anoro Ellipta, Breo Ellipta | $920 | $61,97379 claims |
| Boehringer IngelheimJardiance | $79 | $36,13445 claims |
| AbbVieLinzess, Synthroid | $1,582 | $29,96574 claims |
| Lilly USA, LLCMounjaro | $173 | $29,49523 claims |
| NovartisEntresto | $53 | $21,41122 claims |
| Otsuka America Pharmaceutical, Inc.Rexulti | $259 | $21,35115 claims |
| Astellas Pharma US IncMyrbetriq | $108 | $16,19824 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 1,680 family medicine providers in Alabama.
Other family medicine in Jasper
- John BivonaJasper$18K
- Michael VaughnBirmingham$9.9M
- William NixonGuntersville$7.1M
- Randall QuinnCullman$5.4M
- Matthew CaldwellAthens$4.1M
- Michael CarterHuntsville$3.4M
- Howard RubensteinSaraland$3.3M
- Randle MiddletonHuntsville$3.3M
- Aaron KarrSheffield$3.1M
- Nidal MorrarFoley$3M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.